Articles published by Vistagen
Vistagen to Participate in the Maxim Group Healthcare Virtual Conference Hosted by M-Vest
June 16, 2023
From Vistagen
Via Business Wire
Tickers
VTGN
Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health
May 24, 2023
From Vistagen
Via Business Wire
Tickers
VTGN
Vistagen Presents New Fasedienol (PH94B) Research at 2023 Anxiety and Depression Association of America Conference
April 19, 2023
From Vistagen
Via Business Wire
Tickers
VTGN
Vistagen Receives New European Patent for AV-101
April 06, 2023
From Vistagen
Via Business Wire
Tickers
VTGN
Vistagen Announces Issuance of U.S. Patent for PH80 Nasal Spray for Treatment of Migraine
March 01, 2023
From Vistagen
Via Business Wire
Tickers
VTGN
Vistagen Provides Corporate Update and Reports Fiscal 2023 Third Quarter Financial Results
February 07, 2023
From Vistagen
Via Business Wire
Tickers
VTGN
Vistagen to Report Fiscal Year 2023 Third Quarter Financial Results on February 7, 2023
February 06, 2023
From Vistagen
Via Business Wire
Tickers
VTGN
Vistagen Announces Closing of Pherin Pharmaceuticals Acquisition
February 02, 2023
From Vistagen
Via Business Wire
Tickers
VTGN
Vistagen to Acquire Pherin Pharmaceuticals
December 21, 2022
From Vistagen
Via Business Wire
Tickers
VTGN
Vistagen Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder
December 06, 2022
From Vistagen
Via Business Wire
Tickers
VTGN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.